# US 2008/0189048 A1 · Sequencing of oligonucleotides by mass spectrometry

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0189048 A1
- Document ID: US20080189048A1
- Status: Published application
- Kind: A1
- Application number: 11/945,114
- Filed: 2007-11-26
- Published: 2008-08-07
- Earliest claimed: 2006-11-29
- Assignees: University of Kansas
- Inventors: Heather Desaire; Mary Bandu
- Web page: https://patentgrep.com/patent/US20080189048A1

## CPC

- C12Q 1/6872: involving mass spectrometry
- H01J 49/004: {Combinations of spectrometers, tandem spectrometers, e.g. MS/MS, MSn}
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- H01J: ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS (spark-gaps H01T; electric arc lamps H05B31/00; particle accelerators H05H)

## Abstract

A method of sequencing nucleic acids is provided which uses ion ratios derived by measuring ion abundance at both a high and low collision energy. These ion rations are useful for assigning charge states to product ions, as well as for sequencing the terminal sequences. In addition, methods for using internal ions to sequence the nucleic acids are described.

## Claims

### Claim 1

A method of determining a 5′ terminal base sequence of a parent nucleic acid having a known mass, the method comprising:
obtaining a first tandem mass spectrum of said parent nucleic acid using a first collision energy;
determining an ion abundance of each product ion of interest from said first mass spectrum above a predetermined ion abundance;
obtaining a second tandem mass spectrum of said parent nucleic acid using a second collision energy that is different from said first collision energy;
determining an ion abundance of each product ion of interest from said second mass spectrum above said predetermined ion abundance;
determining an ion ratio defined by the formula: ion ratio=(ion abundance of said product ion of interest in a mass spectrum having a higher collision energy)/(ion abundance of said product ion of interest in a mass spectrum having a lower collision energy);
determining a mass difference between the known mass of the parent nucleic acid and a mass of a product ion of interest having a low ion ratio; and
comparing the obtained mass difference to a predetermined mass value associated with a known 5′ terminal base sequence, wherein the mass difference provides an indication of the 5′ terminal base sequence.

### Claim 2 (depends on 1)

The method of claim 1, wherein said 5′ terminal base sequence comprises a single nucleotide selected from C, T, A, or G, and wherein said predetermined mass value is about 220, 225, 234, or 250 Da, respectively, and wherein a mass difference substantially equal to the predetermined mass value of one of the known 5′ terminal base sequences indicates the 5′ terminal base sequence is the known 5′ base sequence.

### Claim 3 (depends on 1)

The method of claim 1, further comprising:
ranking said ion ratios for each product ion of interest from a lowest to a highest ion ratio;
determining the mass difference between the parent nucleic acid and at least the product ion of interest having the lowest ion ratio in said ranking; and
comparing the mass difference to said predetermined mass value associated with the known 5′ terminal base sequence, wherein the mass difference being substantially the same as the predetermined mass value associated with the known 5′ terminal base sequence identifies the 5′ terminal base sequence of the parent nucleic acid.

### Claim 4 (depends on 1)

The method of claim 1, further comprising:
identifying said ion ratios for each product ion of interest; and
determining the mass differences between the parent nucleic acid and selected product ions of interest from a lowest ion ratio to a highest ion ratio until obtaining a mass difference that is substantially the same as the predetermined mass value of one of the known 5′ terminal base sequences.

### Claim 5 (depends on 1)

The method of claim 1, further comprising:
determining a total product ion area from said first mass spectrum;
determining a product ion area for each product ion of interest from said first mass spectrum;
determining the ion abundance of said product ion of interest in said first mass spectrum according to the formula: ion abundance=(product ion area/total product ion area of first mass spectrum);
determining a total product ion area from said second mass spectrum;
determining a product ion area for each product ion of interest from said second mass spectrum;
determining an ion abundance of said product ion of interest in said second mass spectrum according to the formula: ion abundance=(product ion area/total product ion area of second mass spectrum); and
wherein said ion ratio is determined according to the formula: ion ratio=((Product ion area)/(Total product ion area of the mass spectrum having the higher collision energy))/((Product ion area)/(Total product ion area of the mass spectrum having the lower collision energy)).

### Claim 6 (depends on 5)

The method of claim 5, wherein the total product ion area and product ion area are calculated to:
Total


Product


Ion


Area
=
∑
Lowest


m
/
z
2000

m
/
z


relative


abundance
(
1
)
Product


Ion


Area
=
∑
-
1.0
+
1.0

m
/
z


relative


abundance


(
ion


of


interest
)
(
2
)

### Claim 7

A method of determining a 3′ terminal base sequence of a parent nucleic acid, the method comprising:
obtaining a first tandem mass spectrum of said parent nucleic acid using a first collision energy;
determining an ion abundance of each product ion of interest from said first mass spectrum above a predetermined ion abundance;
obtaining a second tandem mass spectrum using a second collision energy that is different from said first collision energy;
determining an ion abundance of each product ion of interest from said second mass spectrum above said predetermined ion abundance;
determining an ion ratio defined by the formula: ion ratio=(ion abundance of said product ion of interest in a mass spectrum having a higher collision energy)/(ion abundance of said product ion of interest in a mass spectrum having a lower collision energy);
determining a mass-to-charge ratio of an ion of interest having a high ion ratio; and
comparing the obtained mass-to-charge ratio to a predetermined mass-to-charge ratio value associated with a known 3′ terminal base sequence, wherein the mass-to-charge ratio of the ion of interest being substantially equal to the predetermined mass-to-charge ratio value associated with a known 3′ terminal base sequence provides an indication of the 3′ terminal base sequence.

### Claim 8 (depends on 7)

The method of claim 7, further comprising:
ranking said ion ratios for each product ion of interest from a lowest to a highest ion ratio; and
comparing the mass-to-charge ratio of at least the product ion of interest having the highest ion ratio in said ranking.

### Claim 9 (depends on 7)

The method of claim 7, further comprising at least one of the following:
selecting said 3′ terminal base sequence from CC, (CT), (CA), TT, (TA), (GC), AA, (GT), (GA), or GG, and the predetermined value is selected from about 595, 610, 619, 625, 634, 635, 643, 650, 659, and 675, respectively; or
selecting said 3′ terminal base sequence from TCC, T(CT), TTT, T(CA), T(TA), T(GC), TAA, T(GT), T(GA), or TGG, wherein the parenthetical indicates the composition but not the order of the 3′ terminal base sequence.

### Claim 10 (depends on 7)

The method of claim 7, further comprising:
determining a total product ion area from said first mass spectrum;
determining a product ion area for each product ion of interest from said first mass spectrum;
determining the ion abundance of said product ion of interest in said first mass spectrum according to the formula: ion abundance=(product ion area/total product ion area of first mass spectrum);
determining a total product ion area from said second mass spectrum;
determining a product ion area for each product ion of interest from said second mass spectrum;
determining an ion abundance of said product ion of interest in said second mass spectrum according to the formula: ion abundance=(product ion area/total product ion area of second mass spectrum); and
wherein said ion ratio is determined according to the formula: ion ratio=((Product ion area)/(Total product ion area of the mass spectrum having the higher collision energy)/((Product ion area)/(Total product ion area of the mass spectrum having the lower collision energy)).

### Claim 11 (depends on 10)

The method of claim 10, wherein the total product ion area and product ion area are calculated to:
Total


Product


Ion


Area
=
∑
Lowest


m
/
z
2000

m
/
z


relative


abundance
(
1
)
Product


Ion


Area
=
∑
-
1.0
+
1.0

m
/
z


relative


abundance


(
ion


of


interest
)
(
2
)

### Claim 12

A method of sequencing a parent nucleic acid having a known mass, the method comprising:
obtaining a first tandem mass spectrum of the parent nucleic acid using a first collision energy;
determining a mass-to-charge ratio of a smallest [w] ion from said mass spectrum so as to provide a known partial 3′ terminal base sequence;
adding a first hypothetical base to said smallest [w] ion to provide a hypothetical second smallest [w] ion;
determining a hypothetical mass-to-charge ratio of said hypothetical second smallest ion; and
comparing the hypothetical mass-to-charge ratio of said hypothetical second smallest ion to the actual mass-to-charge ratios obtained from said first tandem mass spectrum, wherein when said first hypothetical base causes the hypothetical mass-to-charge ratio of the hypothetical second smallest [w] ion to be substantially equal to an actual mass-to-charge ratio in said spectrum, said parent nucleic acid has a sequence that comprises the first hypothetical base plus the known partial 3′ terminal base sequence.

### Claim 13 (depends on 12)

The method of claim 12, further comprising:
adding a second hypothetical base to said second smallest [w] ion to provide a hypothetical third smallest [w] ion;
determining a hypothetical mass-to-charge ratio of said hypothetical third smallest [w] ion; and
comparing the hypothetical mass-to-charge of said hypothetical third smallest ion to the actual mass-to-charge ratios obtained from said first tandem mass spectrum, wherein when said second hypothetical base causes the hypothetical mass-to-charge ratio of said hypothetical third smallest [w] ion to be substantially equal to an actual mass-to charge ratio in said spectrum, said sequence of the parent nucleic acid comprises the second hypothetical base plus the first hypothetical base plus the known partial 3′ terminal base sequence.

### Claim 14 (depends on 12)

The method of claim 12, further comprising:
determining an ion abundance of each product ion of interest from said first mass spectrum above a predetermined ion abundance;
obtaining a second tandem mass spectrum using a second collision energy that is different from the first collision energy;
determining an ion abundance of each product ion of interest from said second mass spectrum above said predetermined ion abundance;
determining an ion ratio defined by the formula: ion ratio=(ion abundance of said product ion of interest in a mass spectrum having a higher collision energy)/(ion abundance of said product ion of interest in a mass spectrum having a lower collision energy); and
ranking said ion ratios for each product ion of interest from a lowest to a highest ion ratio so that the hypothetical smallest ion [w] has an ion ratio that is no less than the median of all ion ratios for each product ion of interest.

### Claim 15

A method for sequencing a nucleic acid comprising:
obtaining a mass spectrum of the nucleic acid using a first collision energy;
determining a first partial 3′ terminal base sequence of said nucleic acid from a first [w] ion;
combining a first internal ion from said mass spectrum to said first [w] ion to provide a first hypothetical [w] ion;
determining a first hypothetical mass-to-charge ratio of said first hypothetical [w] ion, wherein the charge of the first hypothetical [w] ion is one;
comparing the first hypothetical mass-to-charge ratio of said first hypothetical [w] ion to actual mass-to-charge ratios obtained from said mass spectrum, wherein when said internal ion causes said first hypothetical mass-to-charge ratio of said first hypothetical [w] ion to be substantially equal to an actual mass-to-charge ratio in said spectrum, said nucleic acid has a sequence that comprises the first hypothetical internal ion plus the first partial 3′ terminal base sequence.

### Claim 16 (depends on 15)

The method of claim 15, further comprising:
determining a second partial 3′ terminal base sequence of said nucleic acid from a second [w] ion, said second partial 3′ terminal base sequence being different from said first partial 3′ terminal base sequence;
combining a second internal ion from said mass spectrum to said second [w] ion to provide a second hypothetical [w] ion;
determining a second hypothetical mass-to-charge ratio of said second hypothetical [w] ion; and
comparing the second hypothetical mass-to-charge ratio of said second hypothetical [w] ion to actual mass-to-charge ratios obtained from said mass spectrum, wherein when said second internal ion causes the second hypothetical mass-to-charge ratio of said second hypothetical [w] ion ratio to be substantially equal to an actual mass-to-charge ratio in said spectrum, said nucleic acid has a sequence that comprises the second internal ion plus the second partial 3′ terminal base sequence.

### Claim 17 (depends on 16)

The method of claim 16, further comprising:
determining a base composition between said first hypothetical [w] ion and said second hypothetical [w] ion by determining a mass difference between said first hypothetical [w] ion and said second hypothetical [w] ion; and
optionally, verifying the 3′ terminal base sequence when the said first hypothetical [w] ion and said second hypothetical [w] ion are the same.

### Claim 18 (depends on 16)

The method of claim 16, further comprising:
determining a third 3′ terminal base sequence of said nucleic acid from a third [w] ion, wherein said third [w] ion is selected the group consisting of an actual [w] ion in said mass spectrum, said first hypothetical [w] ion, or said second hypothetical [w] ion; and wherein said third partial 3′ terminal base sequence is different from said first partial 3′ terminal base sequence and said second partial 3′ terminal base sequence;
combining a third internal ion from said mass spectrum to said third [w] ion to provide a third hypothetical [w] ion;
determining a third hypothetical mass-to-charge ratio of said third hypothetical [w] ion; and
comparing the third hypothetical mass-to-charge ratio of said third hypothetical [w] ion to actual mass-to-charge ratios obtained from said mass spectrum, wherein when said third internal ion causes the third hypothetical mass-to-charge ratio of said third hypothetical [w] ion to be substantially equal to an actual mass-to charge ratio in said spectrum, said nucleic acid has a sequence that comprises the third internal ion plus the third partial 3′ terminal base sequence.

### Claim 19 (depends on 18)

The method of claim 18, further comprising at least one of the following:
verifying the partial 3′ terminal base sequence by comparing the second partial 3′ terminal sequence and the third partial 3′ terminal base sequence; or
verifying the 3′ terminal base sequence when the said first hypothetical [w] ion, said second hypothetical [w] ion, and said third hypothetical [w] ion are the same.

### Claim 20

A method for sequencing a nucleic acid comprising:
obtaining a first tandem mass spectrum of the nucleic acid using a first collision energy;
determining a first partial 5′ terminal base sequence of said nucleic acid;
combining a first internal ion from said mass spectrum with said 5′ terminal base sequence to form a first hypothetical [a-Base] ion;
determining a first hypothetical mass-to-charge ratio of said first hypothetical [a-Base] ion; and
comparing the first hypothetical mass-to-charge ratio of said first hypothetical [a-Base] ion to actual mass-to-charge ratios obtained from said mass spectrum, wherein when said first internal ion causes said first hypothetical mass-to-charge ratio of said first hypothetical [a-Base] ion to be substantially equal to an actual mass-to-charge ratio in said spectrum, said nucleic acid includes a sequence that comprises the first hypothetical internal ion plus the 5′ terminal base sequence.

### Claim 21 (depends on 20)

The method of claim 20, further comprising:
determining a second partial 5′ terminal base sequence of said nucleic acid, said second partial 5′ terminal base sequence being different from said first partial 5′ terminal base sequence;
adding a second internal ion from said mass spectrum to said second partial 5′ terminal base sequence to provide a second hypothetical [a-Base] ion;
determining a second hypothetical mass-to-charge ratio of said second hypothetical [a-Base] ion; and
comparing the second hypothetical mass-to-charge ratio of said second hypothetical [a-Base] ion to actual mass-to-charge ratios obtained from said mass spectrum, wherein when said second internal ion causes the second hypothetical mass-to-charge ratio of said second hypothetical [a-Base] ion to be substantially equal to an actual mass-to-charge ratio in said spectrum, said nucleic acid has a sequence that comprises the second internal ion plus the second partial 5′ terminal base sequence.

### Claim 22 (depends on 21)

The method of claim 21, further comprising at least one of the following:
determining a base composition between said first hypothetical [a-Base] ion and said second hypothetical [a-Base] ion by determining a mass difference between said first hypothetical [a-Base] ion and said second hypothetical [a-Base] ion; or
verifying the 5′ terminal base sequence when the said first hypothetical [a-Base] ion and said second hypothetical [a-Base] ion are the same.

### Claim 23 (depends on 21)

The method of claim 21, further comprising the step of:
determining a third 5′ terminal base sequence of said nucleic acid; wherein said third partial 5′ terminal base sequence is different from said first partial 5′ terminal base sequence and said second partial 5′ terminal base sequence;
adding a third internal ion from said mass spectrum to said third 5′ terminal base sequence to provide a third hypothetical [a-Base] ion;
determining a third hypothetical mass-to-charge ratio of said third hypothetical [a-Base] ion; and
comparing the third hypothetical mass-to-charge ratio of said third hypothetical [a-Base] ion to actual mass-to-charge ratios obtained from said mass spectrum, wherein when said third internal ion causes the third hypothetical mass-to-charge ratio of said third hypothetical [a-Base] ion to be substantially equal to an actual mass-to charge ratio in said spectrum, said nucleic acid sequence comprises the third internal ion plus the third partial 5′ terminal base sequence.

### Claim 24 (depends on 23)

The method of claim 23, further comprising verifying the 5′ terminal base sequence when the said first hypothetical [a-Base] ion, said second hypothetical [a-Base] ion, and said third hypothetical [a-Base] ion are the same.

### Claim 25 (depends on 20)

The method of claim 20, further comprising
obtaining a second tandem mass spectrum of said parent nucleic acid using a second collision energy that is different from said first collision energy;
determining an ion abundance of each product ion of interest from said second mass spectrum above said predetermined ion abundance; and
determining an ion ratio, wherein a low ion ratio is indicative of said product ion of interest having a high charge state, a high ion ratio is indicative of said product ion of interest having a low charge state, and an ion ratio near unity is indicative of said product ion of interest having an intermediate charge state, and wherein at least one internal ion has a low charge state.
